经口机器人手术在口咽癌治疗中的研究进展  

Advances of transoral robotic surgery in the treatment of oropharyngeal cancer

作　　者：郭茹燕 翟宋玉 温树信 GUO Ruyan;ZHAI Songyu;WEN Shuxin(The First Clinical College of Shanxi Medical University,Taiyuan,Shanxi 030000,China;Department of Otorhinolaryngology,Head and Neck Surgery,Shanxi Bethune Hospital,The Third Hospital of Shanxi Medical University,Taiyuan,Shanxi 030000,China)

机构地区：[1]山西医科大学第一临床医学院,山西太原030000 [2]山西白求恩医院、山西医科大学第三医院耳鼻咽喉头颈外科,山西太原030000

出　　处：《安徽医药》2023年第9期1732-1735,共4页Anhui Medical and Pharmaceutical Journal

摘　　要：经口机器人手术(TORS)是指以口腔为手术通路的机器人手术。作为一种新的手术方式,TORS的安全性和可行性已被初步证实,并且于2009年被美国食品和药物管理局(FDA)批准使用达芬奇外科系统治疗T1~T2期口咽癌。TORS治疗口咽癌一直是头颈外科领域研究的热点,随着人们对TORS经验的积累及探索,TORS也逐渐应用于晚期口咽癌的治疗和口咽癌的挽救性治疗。尽管TORS越来越多地影响着口咽癌的临床治疗,但其尚有一定的局限性,目前评价TORS发挥的具体作用尚为时过早。Transoral robotic surgery(TORS)refers to the robotic surgery that takes the oral cavity as the surgical pathway.As a new surgical method,TORS has been preliminarily proved to be safe and feasible,and was approved by the United States Food and Drug Administration(FDA)in 2009 to use Leonardo da Vinci surgical system for the treatment of stage T1-T2 oropharyngeal cancer.The use of TORS in the treatment of oropharyngeal cancer has always been a hot topic in the field of head and neck surgery.With the accumulation and exploration of TORS experience,it has been gradually used in the treatment of advanced oropharyngeal cancer and salvage treatment of oropharyngeal cancer.Although TORS increasingly affects the clinical treatment of oropharyngeal cancer,it still has some limitations.Therefore,it is too early to evaluate the specific role of TORS in the treatment of oropharyngeal cancer.

关 键 词：口咽肿瘤 经口机器人手术 手术 综合治疗 

分 类 号：R739.63[医药卫生—肿瘤]